Axel Glaessgen

MRI-Targeted or Standard Biopsy in Prostate Cancer Screening

Martin Eklund, Fredrik Jäderling, Andrea Discacciati et al. · New England Journal of Medicine · 2021 · 354 citations · Full text

Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial

Tobias Nordström, Andrea Discacciati, Martin Bergman et al. · The Lancet Oncology · 2021 · 175 citations

Urology, Cancer Detection, Cancer Screening +7

FISH Analysis of Gene Aberrations (MYC, CCND1, ERBB2, RB, and AR) in Advanced Prostatic Carcinomas Before and After Androgen Deprivation Therapy

Christine Kaltz-Wittmer, Ulrich Klenk, Axel Glaessgen et al. · Laboratory Investigation · 2000 · 96 citations · Full text

Urology, Oncology, Fish Analysis +9

Heat shock proteins 27, 60 and 70 as prognostic markers of prostate cancer

Axel Glaessgen, Sara Jonmarker, Anna Lindberg et al. · Apmis · 2008 · 72 citations

Interobserver Reproducibility of Percent Gleason Grade 4/5 in Prostate Biopsies

Axel Glaessgen, Hans Hamberg, Carl‐Gustaf Pihl et al. · The Journal of Urology · 2004 · 38 citations